Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
“Biological Drug API Manufacturing market set to grow to $11bn by 2025” says Visiongain report
Strengths in the biotech contract manufacturing market, from the perspective of the CMOs, stem from the demand for lower cost manufacturing from companies of all sizes.
07 November 2019
“global radiation oncology market is anticipated to surpass USD 6.5 billion by 2020”, says Visiongain
Growing aging population, urbanization, and growing wealth in low- and middle-income countries such as China and India are anticipated to boost the APAC radiation oncology market.
07 November 2019
“Global Rabies Diagnostics Market is anticipated to surpass USD 1.8 billion by 2020”, says Visiongain
Several international healthcare organizations are working with healthcare organizations to develop and market new detection assays to drive efforts aimed at fighting the disease.
07 November 2019
“Global spinal muscular atrophy (SMA) market is anticipated is to surpass USD 950 Million by 2020”, says Visiongain
Increasing awareness of SMA and increasing numbers of programs to expand treatment options for rare diseases are key factors that are boosting the market growth.
07 November 2019
